Introduction Kidney transplant recipients and patients on the waiting list for kidney transplant
who acquire SARS-CoV-2 infection are at serious risk of developing severe COVID-19, with …

There is no antiviral study on hemodialysis patients infected with coronavirus disease 2019
(COVID‐19), especially on the application of 2′‐deoxy‐2′‐β‐fluoro‐4′‐azidocytidine …

Background Dialysis patients are at risk for lower SARS-CoV-2-vaccine immunogenicity
than the normal population. We assessed immunogenicity to a first mRNA-or vector-based …

Background Hemodialysis patients have faced unique challenges during the COVID-19
pandemic. They face high risk of death if infected and have unavoidable exposure to others …

Background After the reports of severe adverse reactions to the AstraZeneca ChAdOx1-S-
nCoV-19 vaccine, patients who had received one dose of ChAdOx1-S-nCoV-19 vaccine …

Background Vaccination programs are essential for the containment of the coronavirus
disease 2019 pandemic, which has hit haemodialysis populations especially hard. Early …

Methods: Meta-analysis and meta-regression of 13 articles on COVID-19 patients with
chronic kidney disease, with information on diabetes and mortality were performed using …

Introduction: The determinants of COVID-19 mortality are well-characterized in the general
population. Less numerous and inconsistent data are among the maintenance hemodialysis …

Background In centre haemodialysis (ICHD) patients have been identified as high risk of
contracting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection due …

Abstract Introduction: The Omicron variant of the novel coronavirus (COVID-19) has been
spreading more rapidly and is more infectious, posing a higher risk of death and treatment …